Common Contracts
2 similar Confidential Separation Agreement and Release contracts by PDL Biopharma, Inc.
ContractConfidential Separation Agreement and Release • May 5th, 2020 • Nevada
EX-10.2 2 pdli-2017093010qex102.htm EXHIBIT 10.2 Exhibit 10.2 CONFIDENTIAL SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS This Confidential Separation Agreement and Release of All Claims (“Agreement”) is made and entered into by and between DANNY J. HART, JR (hereinafter referred to as “Executive”) and PDL BIOPHARMA, INC., including any and all affiliates, parents, subsidiaries, representatives, agents, insurers, officers, directors, and employees (hereinafter “PDL” or “the Company”). W I T N E S S E T H: WHEREAS, the Parties entered into a Severance Agreement as of December 12, 2012 which, as pertinent, provided Executive with certain “Termination Benefits” in exchange for a Release in the event he resigned from the Company for “Good Reason” as defined in Article 2 of that agreement; and WHEREAS, Executive Claims that “Good Reason” exists for him to resign all of his affiliations including his employment with the Company; WHEREAS, Executive has submitted his resignation to the Company
CONFIDENTIAL SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMSConfidential Separation Agreement and Release • November 13th, 2017 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Nevada
This Confidential Separation Agreement and Release of All Claims (“Agreement”) is made and entered into by and between DANNY J. HART, JR (hereinafter referred to as “Executive”) and PDL BIOPHARMA, INC., including any and all affiliates, parents, subsidiaries, representatives, agents, insurers, officers, directors, and employees (hereinafter “PDL” or “the Company”).
